Australia Dialysis Market Analysis Report 2022 to 2030

Australia Dialysis Market Analysis

$ 3999

Australia's Dialysis Market is projected to grow from $1.395 Bn in 2022 to $2.581 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-2030. The incidence of CKD in Australia is on the rise due to factors such as diabetes and hypertension, which are becoming more prevalent in the country. This is driving the demand for dialysis treatment. Fresenius Medical Care is one of the leading players in the market, with a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services.

ID: IN10AUPH010 CATEGORY: Pharmaceuticals GEOGRAPHY: Australia AUTHOR: Shivam Zalke

Buy Now

Australia Dialysis Market Executive Summary

Australia's Dialysis Market is projected to grow from $1.395 Bn in 2022 to $2.581 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-30.

The dialysis market in Australia is a well-established market with a high penetration of dialysis treatment. The market is driven by factors such as an aging population, an increasing incidence of chronic kidney disease (CKD), and the government's support for the provision of dialysis services.

Some of the key players in the Australia dialysis market include Fresenius Medical Care, Baxter International, and Nipro Medical Corporation. These companies have a significant presence in the market and offer a wide range of products and services for dialysis treatment. Other notable companies in the market include DaVita, Australian Renal Care, and Renal Services.

The Australian government has implemented several policies and regulations to support the development of the dialysis market in the country. Some of these include the Medicare Benefits Schedule (MBS), which covers the cost of dialysis treatment for eligible individuals, and the National Dialysis and Transplantation Outcomes (NDTO) program, which aims to improve the quality and safety of dialysis services.

The Australia dialysis market is segmented into Hemodialysis, Peritoneal Dialysis, and Home Dialysis. Hemodialysis is the most common form of dialysis in Australia, accounting for around 70% of the total dialysis market.

Overall, the dialysis market in Australia is expected to continue to grow in the coming years, driven by factors such as an aging population, an increasing incidence of chronic kidney disease, and the government's support for the provision of dialysis services.

australia dialysis market analysis

Market Dynamics

Market Drivers

The Australia dialysis market is driven by several factors, including:

Increasing incidence of chronic kidney disease (CKD): The incidence of CKD in Australia is on the rise due to factors such as diabetes and hypertension, which are becoming more prevalent in the country. This is driving the demand for dialysis treatment
Aging population: Australia has an aging population, and as the population ages, the number of people with kidney failure is expected to increase, which will drive the demand for dialysis treatment
Government support: The Australian government has implemented several policies and regulations to support the development of the dialysis market in the country, such as the Medicare Benefits Schedule (MBS), which covers the cost of dialysis treatment for eligible individuals, and the National Dialysis and Transplantation Outcomes (NDTO) program, which aims to improve the quality and safety of dialysis services
Increase in home-based dialysis: With the advancement of technology and increasing awareness, home-based dialysis is becoming more popular in Australia, as it is more convenient and less expensive than in-center dialysis
Increasing healthcare expenditure: The rising healthcare expenditure in the country is driving the growth of the dialysis market
Government initiatives: The government is continuously working towards increasing the availability of dialysis services in remote and underserved areas of the country

Overall, these drivers are expected to continue to support the growth of the dialysis market in Australia in the coming years.

Competitive Landscape

Key Players

Some key players in the Australia dialysis market include Fresenius Medical Care, Baxter International, Nipro Medical Corporation, DaVita, Australian Renal Care, and Renal Services. These companies have a significant presence in the market and offer a wide range of products and services for dialysis treatment.

Fresenius Medical Care is one of the leading players in the market, with a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services
Baxter International is another major player in the market, offering a wide range of dialysis products, including hemodialysis machines, dialysis concentrates, and dialysis services
Nipro Medical Corporation is a leading player in the market, offering a wide range of dialysis products, including hemodialysis machines, dialysis concentrates, and dialysis services
DaVita is a leading player in the market, offering a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services
Australian Renal Care is one of the largest providers of dialysis services in Australia, with a network of over 50 clinics across the country
Renal Services is a leading player in the market, offering a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services

Other notable companies in the market include Australian Kidney Care, Dialysis Clinic Inc, and Renal Services.

Healthcare Policies and Regulatory Landscape

The dialysis market in Australia is largely dominated by private providers, with the government playing a role in funding and regulation through the country's public healthcare system, known as Medicare. The Australian government provides funding for dialysis through the Chronic Kidney Disease (CKD) Program, which covers the cost of treatment for eligible patients with chronic kidney disease. The government also regulates the dialysis industry through the Therapeutic Goods Administration (TGA) and the Australian Commission on Safety and Quality in Healthcare (ACSQHC). The TGA is responsible for the registration and approval of dialysis-related medical devices and equipment, while the ACSQHC sets national standards for the safe and quality delivery of dialysis services. Additionally, the government also regulates dialysis providers through the Australian Health Practitioner Regulation Agency (AHPRA) which registers and accredits the health practitioners working in dialysis centers.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Dialysis Market Segmentation

The Dialysis Market is segmented as mentioned below:

By Type (Revenue, USD Billion):

Hemodialysis (HD)
- Conventional Hemodialysis
- Short daily hemodialysis
- Nocturnal hemodialysis
Peritoneal dialysis (PD)
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Automated Peritoneal Dialysis (APD)

By Product & Services (Revenue, USD Billion):

Equipment
- Dialysis Machines
- Water Treatment Systems
- Others Dialysis Equipment
Consumables
- Dialyzers
- Catheters
- Other Dialysis Consumables
Dialysis Drugs
Services

By End User (Revenue, USD Billion):

In-center dialysis
Home dialysis

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.